All terms in NCIT
| Label | Id | Description |
|---|---|---|
| NFATC1 wt Allele | NCIT_C93136 | [Human NFATC1 wild-type allele is located in the vicinity of 18q23 and is approximately 134 kb in length. This allele, which encodes nuclear factor of activated T-cells, cytoplasmic 1 protein, is involved in the regulation of cytokine gene expression.] |
| Nuclear Factor of Activated T-Cells, Cytoplasmic 1 | NCIT_C93137 | [Nuclear factor of activated T-cells, cytoplasmic 1 (943 aa, ~101 kDa) is encoded by the human NFATC1 gene. This protein plays a role in the modulation of cytokine gene transcription.] |
| NFATC2 Gene | NCIT_C93138 | [This gene is involved in cytokine gene transcription.] |
| NFATC2 wt Allele | NCIT_C93139 | [Human NFATC2 wild-type allele is located within 20q13.2-q13.3 and is approximately 176 kb in length. This allele, which encodes nuclear factor of activated T-cells, cytoplasmic 2 protein, plays a role in the mediation of immune responsive gene transcription.] |
| SA03 | NCIT_C20266 | [Provider: Goteborg University, Goteborg, Sweden. No information from provider. This cell line meets the criteria for the use of human embryonic stem cells by federally funded researchers.] |
| Goteborg ES Cell Line | NCIT_C20263 | |
| Karolinska ES Cell Line | NCIT_C20267 | |
| ES Cell Line | NCIT_C20232 | [Stable cell lines derived from embryonic stem cells. They can be propagated indefinitely in the primitive undifferentiated state while remaining pluripotent.] |
| KA08 | NCIT_C20268 | [Provider: Karolinska Institute, Stockholm, Sweden. No information from provider. This cell line meets the criteria for the use of human embryonic stem cells by federally funded researchers.] |
| KA09 | NCIT_C20269 | [Provider: Karolinska Institute, Stockholm, Sweden. No information from provider. This cell line meets the criteria for the use of human embryonic stem cells by federally funded researchers.] |
| KA43 | NCIT_C20273 | [Provider: Karolinska Institute, Stockholm, Sweden. No information from provider. This cell line meets the criteria for the use of human embryonic stem cells by federally funded researchers.] |
| Maria ES Cell Line | NCIT_C20274 | |
| MB01 | NCIT_C20275 | [Provider: Maria Biotech Co. Ltd. - Maria Infertility Hospital Medical Institute, Seoul, Korea. Information from provider and not independently verified by NIH: Cells are positive for cell markers Oct-4, alkaline phosphatase activity and telomerase activity; Differentiate in vitro into mature neuron, glia cells, muscle cells and beating cardiomyocytes; AFP was also detected in this cells. This cell line meets the criteria for the use of human embryonic stem cells by federally funded researchers.] |
| MB02 | NCIT_C20276 | [Provider: Maria Biotech Co. Ltd. - Maria Infertility Hospital Medical Institute, Seoul, Korea. Information from provider and not independently verified by NIH: Cells are positive for cell markers SSEA-3, SSEA-4, Oct-4, alkaline phosphatase activity and telomerase activity; Cells are negative for the cell marker SSEA-1; Cell has normal karyotype (46 XX); Differentiation in vitro into neuron; Cells were cultured in feeder-free culture condition using Matrigel coated plate. This cell line meets the criteria for the use of human embryonic stem cells by federally funded researchers.] |
| KA40 | NCIT_C20270 | [Provider: Karolinska Institute, Stockholm, Sweden. No information from provider. This cell line meets the criteria for the use of human embryonic stem cells by federally funded researchers.] |
| KA41 | NCIT_C20271 | [Provider: Karolinska Institute, Stockholm, Sweden. No information from provider. This cell line meets the criteria for the use of human embryonic stem cells by federally funded researchers.] |
| KA42 | NCIT_C20272 | [Provider: Karolinska Institute, Stockholm, Sweden. No information from provider. This cell line meets the criteria for the use of human embryonic stem cells by federally funded researchers.] |
| MB03 | NCIT_C20277 | [Provider: Maria Biotech Co. Ltd. - Maria Infertility Hospital Medical Institute, Seoul, Korea. Information from provider and not independently verified by NIH: Cells are positive for cell markers SSEA-3, SSEA-4, Oct-4, alkaline phosphatase activity and telomerase activity; Cells are negative for the cell marker SSEA-1; Cell has normal karyotype (46 XX); Differentiation in vitro into neuron; Cells were cultured in feeder-free culture condition using Matrigel coated plate. This cell line meets the criteria for the use of human embryonic stem cells by federally funded researchers.] |
| MizMedi ES Cell Line | NCIT_C20278 | |
| MI01 | NCIT_C20279 | [Provider: MizMedi Hospital - Seoul National University, Seoul, Korea. No information from provider. This cell line meets the criteria for the use of human embryonic stem cells by federally funded researchers.] |